Modification of the
<i>Pseudomonas aeruginosa</i>
toxin 2‐heptyl‐1‐hydroxyquinolin‐4(1
<i>H</i>
)‐one and other secondary metabolites by methyltransferases from mycobacteria
range of secondary metabolites, among them the respiratory toxin 2‐heptyl‐1‐hydroxyquinolin‐4(1H)‐one (2‐heptyl‐4‐hydroxyquinoline N‐oxide, HQNO). Cultures of the emerging cystic fibrosis pathogen Mycobacteroides abscessus detoxify HQNO by methylating the N‐hydroxy moiety. In this study, the class I methyltransferase MAB_2834c and its orthologue from Mycobacterium tuberculosis, Rv0560c, were identified
COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS
申请人:Universität Konstanz
公开号:EP3502095A1
公开(公告)日:2019-06-26
The present invention relates to a compound, which can be used in the prevention and treatment of infections with pathogenic Neisseria species, in particular N. gonorrhoeae and N. meningitidis (the gonococcus and the meningococcus, respectively), and other pathogenic bacteria (e.g. Haemophilus species or Moraxella catarrhalis ), and which can be used for disinfecting a substrate from said bacteria. Moreover, the present invention relates to a corresponding pharmaceutical composition comprising said compound.